Latest news | Skip to main content

Latest news

Catch up with the latest diabetes research news, approvals, and guideline updates.

21-03-2023 | Diabetes prevention | News

Verapamil promising for preserving beta-cell function in children

Two linked randomized trials published in JAMA support a role for verapamil, but not for intensive glycemic control, to slow C-peptide decline in children with newly diagnosed type 1 diabetes.

10-03-2023 | Primary care | News

COORDINATEd intervention boosts optimal prescribing in type 2 diabetes with ASCVD

A multifaceted, clinic-level intervention results in a marked increase in the proportion of people with type 2 diabetes and atherosclerotic cardiovascular disease receiving appropriate medications, shows the COORDINATE randomized trial.

07-03-2023 | Flash glucose monitoring | News

Flash glucose monitoring linked to type 2 diabetes treatment intensification

Use of intermittently scanned continuous glucose monitoring is associated with an increased likelihood for treatment intensification in people with type 2 diabetes, a study shows.

Data for health analytics concept

03-03-2023 | Healthcare systems | News

Health informatics system aids timely, equitable diabetes care

A health informatics system based on routine clinical data helps physicians to prioritize high-risk people with diabetes, deliver more equitable care, and manage healthcare capacity, report researchers.

01-03-2023 | Flash glucose monitoring | News

One-off pre-consultation isCGM use helpful in type 2 diabetes

A short period of intermittently scanned continuous glucose monitoring prior to a first endocrinologist consultation can improve glycemic outcomes for people with type 2 diabetes, report the SPOT FIRST study researchers.

28-02-2023 | Flash glucose monitoring | News

Real-world isCGM benefits shown for people with psychosocial diabetes issues

People with high diabetes distress achieve reductions in glycated hemoglobin and the need for emergency care for acute diabetes complications after starting on intermittently scanned continuous glucose monitoring, report researchers.

24-02-2023 | Risk factors | News

Mortality risk factors vary by age in type 2 diabetes

Hypertension has the largest impact on mortality risk in younger people with type 2 diabetes, whereas chronic kidney disease is a greater threat for older people, shows a population-based study.

15-02-2023 | Flash glucose monitoring | News

ALERTT1: rtCGM alarm benefits persist in long term

The benefits of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes are sustained for at least 2 years, shows the extension of the ALERTT1 study.

Tape measure - overweight obesity concept

14-02-2023 | Obesity | News

Obesity as prevalent in type 1 diabetes as general US population

There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.

08-02-2023 | Heart failure | News

Meta-analysis shows mixed picture for GLP-1 receptor agonists in heart failure

A meta-analysis suggests that glucagon-like peptide-1 receptor agonists may help prevent new-onset heart failure in people with type 2 diabetes.

03-02-2023 | Empagliflozin | News

DINAMO: Empagliflozin shows promise for young people with type 2 diabetes

Empagliflozin, but not linagliptin, provides “clinically relevant” improvements in glycemic control versus placebo in children and adolescents with type 2 diabetes, report the DINAMO investigators.

26-01-2023 | Screening | News

Age 10 years is optimal type 1 diabetes screening point for adolescents

“Almost no one” who is islet autoantibody negative at age 10 years despite a high familial risk for type 1 diabetes will develop clinical diabetes by the age of 18, report researchers.

17-01-2023 | Lifestyle interventions | News

Healthy lifestyle wards off type 2 diabetes microvascular complications

Real-world data from the UK Biobank show the value of a healthy lifestyle in people with type 2 diabetes hoping to avoid microvascular complications.

16-01-2023 | Diet | News

Microbiome support improves type 2 diabetes outcomes

A randomised trial shows that use of a prebiotic fibre-enriched nutritional formula results in improved life quality and, potentially, better glycaemic control in people with type 2 diabetes.

12-01-2023 | Older adults | News

Lower glucose may slow ageing in type 2 diabetes

People with type 2 diabetes who maintain low glycated haemoglobin levels have slower progression of frailty over time than those with higher levels, shows an analysis of Look AHEAD participants.

Pregnancy with insulin pen

10-01-2023 | Pregnancy | News

EXPECT: Degludec noninferior to detemir in pregnancy for type 1 diabetes

Pregnant women with type 1 diabetes can achieve similar glucose control regardless of whether they use insulin degludec or detemir, show the results of the randomised EXPECT trial.

09-01-2023 | Semaglutide | News

FDA approves high-dose semaglutide for adolescents with obesity

Read more about this decision here

20-12-2022 | Dapagliflozin | News

Dapagliflozin on way to EC approval for all heart failure

Click through to read more on this announcement

20-12-2022 | Metformin | News

Metformin linked to reduced risk for joint replacement

Metformin use is associated with a significant reduction in the risk for total knee or hip replacement among people with type 2 diabetes, shows research published in CMAJ.

19-12-2022 | Early onset | News

Global type 2 diabetes burden increasing in adolescents and young adults

The incidence and burden of type 2 diabetes in young people aged 15–39 years are increasing worldwide, show data from the Global Burden of Disease Study.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

The Medicine Matters news service is brought to you in partnership with medwireNews